Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 852 results for "Novartis Company"

Dr Reddy's acquires Habitrol brand

Dr. Reddy's Laboratories acquires Habitrol Brand from Novartis

Pharmaceutical company Dr. Reddy's Laboratories (NYSE:RDY) reported on Thursday the completion of the acquisition of title and rights of Habitrol brand from Novartis Consumer Health under an asset purchase agreement. The company said Habitrol brand ... BusinessWeek, 1 day ago

46 images for Novartis Company

Haaretz, 4 days ago, 17 hours ago
Sky News Australia, 2 weeks ago
Times of Trenton, 1 week ago
Press TV, 2 weeks ago, 1 day ago
Press TV, 3 weeks ago, 3 days ago
Yahoo! News Australia, 3 weeks ago
Fox Cincinnati 92.5, 2 weeks ago

Novartis buys 12.8% stake in BioLineRX

Swiss drugmaker Novartis AG bought a 12.8 per cent stake in Israeli biopharmaceutical company BioLineRX Ltd as part of a multi-year collaboration deal, BioLineRX said on Tuesday.Under the agreement, Novartis, which invested an initial $10 million, ...
 Business Standard3 days ago Novartis buys 12.8 per cent stake in BioLineRX in co-development deal  Economic Times4 days ago Novartis buys 12.8 pct stake in BioLineRX in co-development deal  Reuters4 days ago BioLineRX signs Novartis strategic cooperation deal  Globes4 days ago
Business Today India

Govt studying options as Novartis-Cipla patent dispute moves to court

The Government is examining if it can move on Indian drug-maker Cipla's demand for revocation of Swiss company Novartis patents on respiratory drug Onbrez. Both the companies are now fighting a case over the drug in court. We are keenly watching ...
 Hindu Business Line2 days ago Novartis sues Cipla for ignoring its COPD drug patents  FiercePharma3 days ago Novartis sues Cipla over respiratory drug Onbrez  Yahoo! Finance3 days ago Judgment reserved on Novartis-Cipla patent dispute  FirstWord Pharma4 days ago

Novartis moves court seeking to restrain Cipla from selling respiratory drug Onbrez

MUMBAI: After the bitter patent fights on HIV, cancer and diabetes drugs between MNCs and domestic companies, the focus is now shifting to non-communicable diseases like respiratory and lung ailments. Drug MNC Novartis has moved the Delhi high court ...
 Economic Times3 days ago Novartis drags Cipla to court  Times of India4 days ago

Novartis gets clinical trial waiver for its Cushing's disease drug Pasireotide

The Union health ministry has given permission to multinational drug company Novartis to import and market its Cushing's disease drug, Pasireotide, without conducting any local clinical trial on Indian population. Senior officials said that the ...
 PharmaBiz2 days ago Novartis profits soar 45 per cent on new drug sales  Economic Times1 month ago Novartis sees new heart failure drug as 'multi-blockbuster'  Reuters1 month ago
Business Standard

Novartis India slips on buzz of NPPA penalty

on a media report that the drug pricing regulator has slapped Rs 300 crore penalty on the company. Meanwhile, the BSE Sensex was down 113.78 points, or 0.43%, to 26,183.60. On BSE, so far 23,000 shares were traded in the counter, compared with an average ...
 Business Standard2 months ago NPPA slaps Rs 300-crore penalty on Novartis  Business Standard2 months ago

Novartis plunges on NPPA`s penalty

Novartis India , one of the leading pharma companies, witnessed a sharp fall on Monday after National Pharmaceutical Pricing Authority (NPPA) imposed a fine of around Rs 3 billion. The NPPA has imposed a fine for overcharging consumers on sale of Voveran, its ...
 Myiris2 months ago
Pharmaceutical Technology

Novartis gains FDA approval for Signifor® LAR to treat patients with acromegaly, a rare and life-threatening hormonal disorder - HTML (w)

Company : NOVARTIS Compartment : Other ISIN : CH0012005267 Wire : Thomson Reuters ONE Document type : Permanent Information Releases / General Company News Publication date : 12/16/2014 7:15:00 AM ...
 WorldRegInfo4 days ago Fresh off Afinitor failure, Novartis turns tide with Signifor LAR approval  FiercePharma4 days ago Novartis wins an FDA nod for a long-acting spin on its rare disease drug  FierceBiotech4 days ago FDA Approves Novartis AG (NVS) Drug For Rare Hormonal Disorder 12/16/2014  ClinicSpace4 days ago

Most Influential 2014: David Pyott [The Orange County Register]

Dec. 19--Age: 61 Job: Chairman and CEO, Allergan Inc Bio: Led the nutrition division at the Swiss drug company Novartis. Since becoming Allergan's CEO, in 1998, the company's annual sales have jumped more than sevenfold, to about $7 billion this ...
 BusinessWeek1 day ago
Bidness Etc

GSK Shareholders In Favor Of Novartis (NVS) Deal

GlaxoSmithKline plc (ADR) ( NYSE:GSK ) announced that its shareholders voted in overwhelming majority in favor of the company's multi-billion swapping deal with Novartis AG (ADR) ( NYSE:NVS ) in the annual shareholder meeting held on December 18. ...
 Bidness Etc1 day ago GSK shareholders give green light to Novartis deal  Invezz1 day ago GSK shareholders approve Novartis deal  BullBearings2 days ago GlaxoSmithKline shareholders back Novartis transaction  FirstWord Pharma2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less